Kairos Ventures, a venture capital firm with ties to multiple academic institutions, hopes to raise $250m for its third main fund.
Kairos Ventures, a US-based venture capital firm focused on academic and industry innovation, is looking to raise $250m for its third main fund, according to a regulatory filing.
Founded in 2015, Kairos Ventures backs companies in the life sciences, physical sciences and technology spaces.
The firm typically supplies between $150,000 and $20m depending on the stage of investment, and also provides expertise and contacts.
Kairos’s earlier bets include Harvard University’s gene-editing technology developer Beam Therapeutics, Caltech-founded…
